Home » Reports » Broker Ratings » GlaxoSmithKline plc 20.6% Potential Upside Indicated by HSBC
Analyst Broker Ratings

GlaxoSmithKline plc 20.6% Potential Upside Indicated by HSBC

GlaxoSmithKline plc with EPIC/TICKER (LON:GSK) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ this morning by analysts at HSBC. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. HSBC have set a target price of 1860 GBX on its stock. This would imply the analyst believes there is now a potential upside of 20.6% from today’s opening price of 1542.4 GBX. Over the last 30 and 90 trading days the company share price has increased 23.2 points and decreased 16 points respectively. The 1 year high share price is 1648.8 GBX while the year low share price is currently 1179.39 GBX.

GlaxoSmithKline plc has a 50 day moving average of 1,511.91 GBX and a 200 Day Moving Average share price is recorded at 1,539.30. There are currently 4,964,922,506 shares in issue with the average daily volume traded being 7,669,226. Market capitalisation for LON:GSK is £77,492,512,897 GBP.